Saudi Food and Drug Authority - Regulatory authority for pharmaceuticals and medical devices in Saudi Arabia
显示 2022 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| Xcard | Hetero Labs Limited Unit – V | Tablet | Jan 1, 2022 | Generic |
| Orziban | UNITED PHARMACEUTICAL COMPANY | Orodispersible tablet | Jan 1, 2022 | Generic |
| Xcard | Hetero Labs Limited Unit – V | Tablet | Jan 1, 2022 | Generic |
| Xcard | Hetero Labs Limited Unit – V | Tablet | Jan 1, 2022 | Generic |
| Xcard | Hetero Labs Limited Unit – V | Tablet | Jan 1, 2022 | Generic |
| DIVAD 5000 I.U CAPSULE | DAR ALDAWA | Capsule, hard | Jan 1, 2022 | Generic |
| Dapxiga | Hetero Labs Limited Unit – III | Film-coated tablet | Jan 1, 2022 | Generic |
| ENOXA | LES LABORATOIRES MEDIS | Solution for injection | Jan 1, 2022 | Biological |
| Valgiver | BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A | Film-coated tablet | Jan 1, 2022 | Generic |
| VITAROS 3MG/GM CREAM | GROUPE PARIMA INC | Cream | Jan 1, 2022 | NCE |
| Pulmirema 0.5 mg | Cipla Limited | Nebuliser suspension | Jan 1, 2022 | Generic |
| VASCEPA 1GM CAPSULE | Patheon Soft Gels BV | Capsule, soft | Jan 1, 2022 | NCE |
| Sulmetic | Aurobindo Pharma Limited Unit III | Film-coated tablet | Jan 1, 2022 | Generic |
| Anidulafungin BOS | Actavis Italy SpA | Powder for concentrate for solution for infusion | Jan 1, 2022 | Generic |
| Trepadio | Jazeera Pharmaceutical Industries (JPI) | Film-coated tablet | Jan 1, 2022 | Generic |
| Pulmirema 0.25 mg | Cipla Limited | Nebuliser suspension | Jan 1, 2022 | Generic |
| Trepadio | Jazeera Pharmaceutical Industries (JPI) | Film-coated tablet | Jan 1, 2022 | Generic |
| Pulmirema 1 mg | Cipla Limited | Nebuliser suspension | Jan 1, 2022 | Generic |
| Lyumjev KwikPen | Eli Lilly and Company, Clinton Laboratories | Solution for injection | Jan 1, 2022 | Biological |
| ATIQUIX | DR. REDDY | Film-coated tablet | Jan 1, 2022 | Generic |
